PF-Atlas › Clinical Trials › NCT05980221

The Development of a Metabolomic Test to Diagnose and Quantify Pancreatic Exocrine Insufficiency

Metabolomics · Not specified

Registry ID

NCT05980221

Phase

Not specified

Status

Unknown

Drug / intervention

Metabolomics

Sponsor

University Hospital Birmingham NHS Foundation Trust

Start

2020-08-24

About this trial

Metabolomics is evaluated in NCT05980221, a idiopathic pulmonary fibrosis study sponsored by University Hospital Birmingham NHS Foundation Trust. Current status: Unknown.

View NCT05980221 on ClinicalTrials.gov →

Explore related

All Metabolomics trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT05980221 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.